增强线粒体钙摄取可抑制代谢综合征相关房颤
该研究在代谢综合征患者右房组织和高脂蔗糖饮食小鼠中,发现线粒体钙单向转运体复合物(MCUC)活性受损与线粒体钙摄取下降,且小鼠房颤易感性增加70%。MCUC激动剂山奈酚可恢复MCUC活性并消除小鼠房颤发生,提示调控MCUC是潜在抗心律失常策略。
要点
- 代谢综合征患者及高脂饮食小鼠心房组织MCUC活性受损、线粒体钙摄取下降。
- 高脂蔗糖饮食小鼠房颤易感性增加70%,早期即出现线粒体钙稳态异常。
- MCUC激动剂山奈酚可恢复MCUC活性并消除小鼠房颤发生。
核心结论
- 代谢性心肌病早期MCUC活性受损和线粒体钙稳态异常可导致房颤,调控MCUC活性是潜在抗心律失常策略。
研究设计与样本
- 研究共纳入161只小鼠和34例患者,患者右房组织分为代谢综合征组(n=18)和无代谢综合征组(n=16)。
- C57Bl/6J小鼠接受高脂蔗糖饮食2周(n=42)或12周(n=39),评估离体窦房组织及在体房颤易感性。
主要发现
- 患者中MCUC的MICUs亚基表达增加(1.00 ± 0.33 AU vs 1.29 ± 0.23 AU;P = 0.034),线粒体钙摄取受损(168.7 ± 31.3 nmol/min/mg vs 127.3 ± 18.4 nmol/min/mg;P = 0.026)。
- 高脂蔗糖饮食小鼠线粒体钙摄取下降:2周(0.10 ± 0.04 ΔF/F0 × ms-1 vs 0.06 ± 0.03 ΔF/F0 × ms-1;P = 0.0086),12周(0.15 ± 0.07 ΔF/F0 × ms-1 vs 0.046 ± 0.03 ΔF/F0 × ms-1;P = 0.0076)。
- 高脂蔗糖饮食小鼠房颤易感性增加70%,MCUC激动剂山奈酚在体外恢复MCUC活性并消除小鼠房颤发生。
临床怎么用
- 对代谢综合征患者应关注房颤风险,其心房组织存在线粒体钙处理缺陷。
- MCUC活性调控可能成为代谢综合征相关房颤的潜在治疗靶点,但尚需临床验证。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with metabolic syndrome (MetS) have an increased risk of atrial fibrillation (AF). Impaired Ca2+ homeostasis and mitochondrial dysfunction have emerged as an arrhythmogenic substrate in both patients and animal models of MetS. Whether impaired mitochondrial Ca2+ handling underlies AF associated with MetS remains poorly explored. OBJECTIVES: The aim of this study was to determine the initial mechanisms related to AF susceptibility and mitochondrial dysfunction encountered in metabolic cardiomyopathy. METHODS: A total of 161 mice and 34 patients were studied. Mitochondrial Ca2+ and mitochondrial Ca2+ uniporter complex (MCUC) were investigated in right atrial tissue of patients with (n = 18) or without (n = 16) MetS and of C57Bl/6J mice fed with a high-fat sucrose diet (HFS) for 2 (n = 42) or 12 (n = 39) weeks. Susceptibility to AF was evaluated in isolated sinoatrial tissue and in vivo in mice. RESULTS: Increased expression of the MICUs subunits of the MCUC (1.00 ± 0.33 AU vs 1.29 ± 0.23 AU; P = 0.034) was associated with impaired mitochondrial Ca2+ uptake in patients (168.7 ± 31.3 nmol/min/mg vs 127.3 ± 18.4 nmol/min/mg; P = 0.026) and HFS mice (0.10 ± 0.04 ΔF/F0 × ms-1 vs 0.06 ± 0.03 ΔF/F0 × ms-1; P = 0.0086, and 0.15 ± 0.07 ΔF/F0 × ms-1 vs 0.046 ± 0.03 ΔF/F0 × ms-1; P = 0.0076 in 2- and 12-week HFS mice, respectively). HFS mice elicited a 70% increased susceptibility to AF. The MCUC agonist kaempferol restored MCUC activity in vitro and abolished the occurrence of AF in HFS mice. CONCLUSIONS: Impaired MCUC activity and mitochondrial Ca2+ homeostasis from the early stage of metabolic cardiomyopathy in mice lead to AF. Given that similar defects in cardiac mitochondrial Ca2+ handling are present in MetS patients, the modulation of the MCUC activity represents an attractive antiarrhythmic strategy.
引用
- Fossier L, Panel M, Butruille L, et al. Enhanced Mitochondrial Calcium Uptake Suppresses Atrial Fibrillation Associated With Metabolic Syndrome. J Am Coll Cardiol. 2022. PMID: 36456051. doi:10.1016/j.jacc.2022.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。